Back to Search
Start Over
Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
- Source :
- British Journal of Nutrition; 10/28/2015, Vol. 114 Issue 8, p1263-1277, 15p
- Publication Year :
- 2015
-
Abstract
- The polyphenol quercetin may prevent CVD due to its antihypertensive and vasorelaxant properties. We investigated the effects of quercetin after regular intake on blood pressure (BP) in overweight-to-obese patients with pre-hypertension and stage I hypertension. In addition, the potential mechanisms responsible for the hypothesised effect of quercetin on BP were explored. Subjects (n 70) were randomised to receive 162 mg/d quercetin from onion skin extract powder or placebo in a double-blinded, placebo-controlled cross-over trial with 6-week treatment periods separated by a 6-week washout period. Before and after the intervention, ambulatory blood pressure (ABP) and office BP were measured; urine and blood samples were collected; and endothelial function was measured by EndoPAT technology. In the total group, quercetin did not significantly affect 24 h ABP parameters and office BP. In the subgroup of hypertensives, quercetin decreased 24 h systolic BP by −3·6 mmHg (P=0·022) when compared with placebo (mean treatment difference, −3·9 mmHg; P=0·049). In addition, quercetin significantly decreased day-time and night-time systolic BP in hypertensives, but without a significant effect in inter-group comparison. In the total group and also in the subgroup of hypertensives, vasoactive biomarkers including endothelin-1, soluble endothelial-derived adhesion molecules, asymmetric dimethylarginine, angiotensin-converting enzyme activity, endothelial function, parameters of oxidation, inflammation, lipid and glucose metabolism were not affected by quercetin. In conclusion, supplementation with 162 mg/d quercetin from onion skin extract lowers ABP in patients with hypertension, suggesting a cardioprotective effect of quercetin. The mechanisms responsible for the BP-lowering effect remain unclear. [ABSTRACT FROM AUTHOR]
- Subjects :
- LIPID metabolism
AMBULATORY blood pressure monitoring
BIOMARKERS
BLOOD pressure
BLOOD sugar
BODY composition
C-reactive protein
CHOLESTEROL
STATISTICAL correlation
CROSSOVER trials
DIETARY supplements
DRUGS
ENDOTHELIUM
HEART beat
ANTIHYPERTENSIVE agents
INGESTION
INSULIN
OBESITY
ONIONS
PATIENT compliance
PLACEBOS
PROBABILITY theory
QUERCETIN
RESEARCH evaluation
RESEARCH funding
STATISTICS
T-test (Statistics)
TRIGLYCERIDES
PLANT extracts
DATA analysis
BODY mass index
RANDOMIZED controlled trials
TREATMENT effectiveness
INTER-observer reliability
BLIND experiment
FOOD diaries
WAIST circumference
DESCRIPTIVE statistics
PREHYPERTENSION
MANN Whitney U Test
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 00071145
- Volume :
- 114
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- British Journal of Nutrition
- Publication Type :
- Academic Journal
- Accession number :
- 110356929
- Full Text :
- https://doi.org/10.1017/S0007114515002950